This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Meda Pharma Gmbh & Co. Kg. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Muhlheim, DE (2012)
- Muehlheim, DE (2012)
Company Filing History:
Years Active: 2012
Title: Beatrix Fyrnys: Innovator in Respiratory Disease Treatment
Introduction
Beatrix Fyrnys is a prominent inventor based in Mühlheim, Germany. She has made significant contributions to the field of respiratory medicine, particularly through her innovative patent work. With a total of two patents to her name, Fyrnys is recognized for her advancements in pharmaceutical compositions aimed at treating respiratory diseases.
Latest Patents
Fyrnys's latest patents include a combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases. This patent focuses on pharmaceutical compositions that include an anticholinergic and at least one leukotriene inhibitor for the treatment of conditions such as allergic rhinitis, bronchial asthma, COPD, and the common cold. Another notable patent involves a combination of anticholinergics and inhibitors of phosphodiesterase type 4 for treating respiratory diseases. This invention relates to a combination of an inhaled or oral PDE 4 inhibitor with inhaled anticholinergic bronchodilators, specifically targeting chronic obstructive pulmonary disease (COPD) and asthma.
Career Highlights
Fyrnys is currently employed at Meda Pharma GmbH & Co. KG, where she continues to develop innovative solutions for respiratory health. Her work has been instrumental in advancing treatment options for patients suffering from various respiratory conditions.
Collaborations
Some of her notable coworkers include Istvan Szelenyi and Joachim Maus, who have collaborated with her on various projects within the pharmaceutical field.
Conclusion
Beatrix Fyrnys stands out as a key figure in the innovation of treatments for respiratory diseases. Her patents reflect her commitment to improving patient care and advancing medical science. Her contributions are vital in the ongoing battle against respiratory ailments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile